Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Svetlana D. Bezhanova"'
Autor:
Nikolay E. Kushlinskii, Olga V. Kovaleva, Arseniy G. Basov, Yurii B. Kuzmin, Aleksandr A. Alferov, Svetlana D. Bezhanova, Aleksey V. Kolpashchikov, Igor A. Klimanov, Alexey N. Grachev, Natalia N. Zybina, Vsevolod B. Matveev, Oleg O. Yanushevich, Ivan S. Stilidi
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 52, Iss 3, Pp 107-119 (2024)
Background: Galectins are a family of β-galactoside binding proteins that regulate the vast majority of cellular functions, including proliferation, migration, adhesion, and phagocytosis in both health and disease. More and more experimental and cli
Externí odkaz:
https://doaj.org/article/3dc7de3dbc9b49969eb33690ddc7e80c
Autor:
Mikhail V. Kiselevskiy, Elena G. Gromova, Nikolay A. Kozlov, Svetlana D. Bezhanova, Irina Zh. Shubina
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 3, Pp 511-518 (2023)
Transmission of a malignancy from a donor’s organ to the recipient of the graft is a rare event, though it is a severe complication that can result in a poor outcome. Usually, immunosuppressive therapy is discontinued and the allograft is removed.
Externí odkaz:
https://doaj.org/article/6857376353c44a469b46c361c3d85817
Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients
Autor:
E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii
Publikováno v:
Onkourologiâ, Vol 16, Iss 4, Pp 39-47 (2021)
Background. The most important task in the field of renal-cell cancer (RCC) treatment results improvement is the search and validation of the markers for its early diagnostics still absent in the clinical practice. It was established that even before